- £196.16bn
- £215.32bn
- $54.07bn
- 85
- 17
- 83
- 70
REG - AstraZeneca PLC - LYNPARZAT APPROVED IN THE EUROPEAN UNION <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - MOVENTIG approved in the EU for OIC <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Jury verdict favours AZ in Nexium litigation <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - New Drug Application for IRESSA accepted by US FDA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Blocklisting Interim Review <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Publication of Final Terms <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - DUAKLIR GENUAIR APPROVED IN THE EU FOR COPD <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Launch and Pricing of a ?750m Bond <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - Citigroup Global Mkt AstraZeneca PLC - Stabilisation Notice <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ strategy on track to deliver growth and value <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">BLND.L</Origin>
AnnouncementREG - AstraZeneca PLC - Publication of Supplementary Prospectus <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - ASTRAZENECA TO DIVEST MYALEPT TO AEGERION <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - 3rd Quarter Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - 3rd Quarter Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - AstraZeneca PLC - 3rd Quarter Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
Announcement